Chemotherapy Induced Anemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
The Chemotherapy-induced Anemia pipeline market research report provides a comprehensive overview on the therapeutics under development for Chemotherapy-induced Anemia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Chemotherapy-induced Anemia and features dormant and discontinued projects.
Key Targets in the Chemotherapy-induced Anemia Pipeline Drugs Market
In the Chemotherapy-induced Anemia pipeline drugs market the key targets are Erythropoietin Receptor, Activin Receptor Type 1, Egl Nine Homolog 1, Iron, Scavenger Receptor Cysteine Rich Type 1 Protein M130, TGF Beta Receptor Type 1, and Transmembrane Prolyl 4 Hydroxylase.
Chemotherapy-induced Anemia Drugs Market, by Targets
For more target insights, download a free report sample
Key MoA in the Chemotherapy-induced Anemia Pipeline Drugs Market
Erythropoietin Receptor Agonist has the highest number of pipeline products followed by Activin Receptor Type 1 Inhibitor, Egl Nine Homolog 1 Inhibitor, Iron Replacement, Scavenger Receptor Cysteine Rich Type 1 Protein M130 Agonist, TGF Beta Receptor Type 1 Inhibitor, and Transmembrane Prolyl 4 Hydroxylase Inhibitor.
Chemotherapy-induced Anemia Pipeline Drugs Market, by MoA
To get more insights on key MoA, download a free sample report
Chemotherapy-induced Anemia Pipeline Drugs Market Segmentation by RoA
The key routes of administration in the Chemotherapy-induced Anemia pipeline drugs market are Oral, Intravenous, and Subcutaneous. Oral has the maximum number of pipeline products.
Chemotherapy-induced Anemia Pipeline Drugs Market Analysis, by RoA
To get more insights on key RoA, download a free sample report
Key Molecule Types in the Chemotherapy-induced Anemia Pipeline Drugs Market
The key molecule types in the Chemotherapy-induced Anemia pipeline drugs market Recombinant Protein, Small Molecule, Fusion Protein, and Monoclonal Antibody.
Chemotherapy-induced anemia Pipeline Drugs Market, by Molecule Type
To get more insights on key molecule types, download a free sample report
Major Companies in the Chemotherapy-Induced Anemia Pipeline Drugs Market
The major companies in the Chemotherapy-Induced Anemia pipeline drugs market are Avesthagen Ltd, FibroGen Inc, General Biologics Inc, Imagine Pharma LLC, Jecho Biopharmaceuticals Co Ltd, Panacea Biotec Ltd, PharmaEssentia Corp, PhytoHealth Corp, Resilience Biotechnologies Inc, SBI Pharmaceuticals Co Ltd, Sumitomo Dainippon Pharma Oncology, Inc, UBI Pharma Inc, Vifor Pharma Ltd, and Zydus Lifesciences Ltd.
Chemotherapy-Induced Anemia Pipeline Drugs Market Overview
Key Targets | Erythropoietin Receptor, Activin Receptor Type 1, Egl Nine Homolog 1, Iron, Scavenger Receptor Cysteine Rich Type 1 Protein M130, TGF Beta Receptor Type 1, and Transmembrane Prolyl 4 Hydroxylase |
Key Mechanisms of action | Erythropoietin Receptor Agonist, Activin Receptor Type 1 Inhibitor, Egl Nine Homolog 1 Inhibitor, Iron Replacement, Scavenger Receptor Cysteine Rich Type 1 Protein M130 Agonist, TGF Beta Receptor Type 1 Inhibitor, and Transmembrane Prolyl 4 Hydroxylase Inhibitor |
Key Routes of Administration | Oral, Intravenous, and Subcutaneous |
Key Molecule Types | Recombinant Protein, Small Molecule, Fusion Protein, and Monoclonal Antibody |
Major Companies | Avesthagen Ltd, FibroGen Inc, General Biologics Inc, Imagine Pharma LLC, Jecho Biopharmaceuticals Co Ltd, Panacea Biotec Ltd, PharmaEssentia Corp, PhytoHealth Corp, Resilience Biotechnologies Inc, SBI Pharmaceuticals Co Ltd, Sumitomo Dainippon Pharma Oncology, Inc, UBI Pharma Inc, Vifor Pharma Ltd, and Zydus Lifesciences Ltd |
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Chemotherapy-Induced Anemia
- The pipeline guide reviews pipeline therapeutics for Chemotherapy-Induced Anemia by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Chemotherapy-Induced Anemia therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Chemotherapy-Induced Anemia therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA), and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews the latest news related to pipeline therapeutics for Chemotherapy-Induced Anemia
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with a potentially strong product portfolio and create effective counter strategies to gain a competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Chemotherapy-Induced Anemia
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and their most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Chemotherapy-Induced Anemia pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from the pipeline.
FibroGen Inc
General Biologics Inc
Imagine Pharma LLC
Jecho Biopharmaceuticals Co Ltd
Panacea Biotec Ltd
PharmaEssentia Corp
PhytoHealth Corp
Resilience Biotechnologies Inc
SBI Pharmaceuticals Co Ltd
Sumitomo Dainippon Pharma Oncology, Inc
UBI Pharma Inc
Vifor Pharma Ltd
Zydus Lifesciences Ltd
Table of Contents
Frequently asked questions
-
What are the key targets in the Chemotherapy-Induced Anemia pipeline drugs market?
In the Chemotherapy-Induced Anemia pipeline drugs market the key targets are Erythropoietin Receptor, Activin Receptor Type 1, Egl Nine Homolog 1, Iron, Scavenger Receptor Cysteine Rich Type 1 Protein M130, TGF Beta Receptor Type 1, and Transmembrane Prolyl 4 Hydroxylase.
-
What are the key mechanisms of action in the Chemotherapy-Induced Anemia pipeline drugs market?
In the Chemotherapy-Induced Anemia pipeline drugs market the key mechanisms of action are Erythropoietin Receptor Agonist, Activin Receptor Type 1 Inhibitor, Egl Nine Homolog 1 Inhibitor, Iron Replacement, Scavenger Receptor Cysteine Rich Type 1 Protein M130 Agonist, TGF Beta Receptor Type 1 Inhibitor, and Transmembrane Prolyl 4 Hydroxylase Inhibitor.
-
What are the key routes of administration in the Chemotherapy-Induced Anemia pipeline drugs market?
The key routes of administration in the Chemotherapy-Induced Anemia pipeline drugs market are Oral, Intravenous, and Subcutaneous.
-
What are the key molecule types in the Chemotherapy-Induced Anemia pipeline drugs market?
The key molecule types in the Chemotherapy-Induced Anemia pipeline drugs market Recombinant Protein, Small Molecule, Fusion Protein, and Monoclonal Antibody.
-
What are the major companies in the Chemotherapy-Induced Anemia pipeline drugs market?
In the Chemotherapy-Induced Anemia pipeline drugs market the major companies are Avesthagen Ltd, FibroGen Inc, General Biologics Inc, Imagine Pharma LLC, Jecho Biopharmaceuticals Co Ltd, Panacea Biotec Ltd, PharmaEssentia Corp, PhytoHealth Corp, Resilience Biotechnologies Inc, SBI Pharmaceuticals Co Ltd, Sumitomo Dainippon Pharma Oncology, Inc, UBI Pharma Inc, Vifor Pharma Ltd, and Zydus Lifesciences Ltd.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.
Related reports
View more Toxicology reports

